Febuxostat is a xanthine oxidase inhibitor (non-purine) indicated for chronic management of hyperuricemia in adults with gout. We supply it to US manufacturers of tablets.
Data from PubChem (CID 134018) and FDA’s substance registry
CAS number
144060-53-7
Molecular formula
C16H16N2O3S
Molecular weight
316.4g/mol
FDA UNII
IUPAC name
2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid
InChIKey
BQSJTQLCZDPROO-UHFFFAOYSA-N
- Appearance
- White to off-white, non-hygroscopic crystalline powder.
- Solubility
- Practically insoluble in water. Freely soluble in dimethylformamide, soluble in dimethyl sulfoxide and sparingly soluble in ethanol.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
Known for its many crystal forms. State the polymorph you developed with, and ask how the source controls form through milling and storage.
On the US market
- Reference product
- UloricNDA 021856
- Approved ANDAs
- 12 with a marketed product
- Approved forms and strengths
- Tablet 40 mg, 80 mg
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com